Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/24/2023* 16:30 EST Earnings Call Q4 2022 -- -- --
02/24/2023* -- Results Q4 2022 -- -1.19 --
11/03/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/03/2022 -- Results Q3 2022 -1.28 -1.18 -8.92%
08/04/2022 16:30 EST Earnings Call Q2 2022 -- -- --
08/04/2022 -- Results Q2 2022 -0.23 -1.01 77.32%
05/04/2022 16:30 EST Earnings Call Q1 2022 -- -- --
05/04/2022 -- Results Q1 2022 -1.02 -0.94 -9.05%
*Estimated Date/Time

Earnings

Next Report Date 02/24/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2022
Beat/Miss Upgrade
Return Since 13.23%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.
URL https://cytokinetics.com
Investor Relations URL https://ir.cytokinetics.com
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
16.16%
-32.92%
-22.45%
67.88%
95.85%
119.3%
0.53%
-1.77%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
15.23%
-1.33%
40.20%
22.42%
-7.07%
1.86%
49.38%
-7.22%
-36.56%
-37.30%
-25.55%
67.36%
-51.25%
-27.69%
175.2%
-3.09%
--
--
--
278.5%
216.2%
-56.00%
5.66%
41.43%
--
--
--
--
34.84%
28.95%
50.00%
-2.30%
As of February 03, 2023.

Profile

Edit
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.
URL https://cytokinetics.com
Investor Relations URL https://ir.cytokinetics.com
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
FIJYX 54.12M USD 3.02%
FBIOX 98.72M USD 1.91%
LADSX 45.97M USD 1.77%
LGLQX 85.91M USD 1.58%
XBI 96.38M USD 1.11%
SLYG 20.94M USD 0.84%
IJT 44.87M USD 0.82%
SPSM 23.08M USD 0.43%
VSMSX 18.34M USD 0.42%
VIOO 18.34M USD 0.42%
VTSIX 36.25M USD 0.42%
IJR 301.71M USD 0.42%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter CYTK Tweets